JP2012500778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012500778A5 JP2012500778A5 JP2011523280A JP2011523280A JP2012500778A5 JP 2012500778 A5 JP2012500778 A5 JP 2012500778A5 JP 2011523280 A JP2011523280 A JP 2011523280A JP 2011523280 A JP2011523280 A JP 2011523280A JP 2012500778 A5 JP2012500778 A5 JP 2012500778A5
- Authority
- JP
- Japan
- Prior art keywords
- chr
- compound
- saturated
- formula
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 claims 56
- 229920006395 saturated elastomer Polymers 0.000 claims 36
- 125000001424 substituent group Chemical group 0.000 claims 27
- 125000004432 carbon atom Chemical group C* 0.000 claims 26
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 25
- 150000003839 salts Chemical class 0.000 claims 22
- 125000000547 substituted alkyl group Chemical group 0.000 claims 22
- 102000001307 androgen receptors Human genes 0.000 claims 17
- 108010080146 androgen receptors Proteins 0.000 claims 17
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 125000003118 aryl group Chemical group 0.000 claims 11
- 125000004122 cyclic group Chemical group 0.000 claims 11
- 230000000694 effects Effects 0.000 claims 11
- 102000007399 Nuclear hormone receptor Human genes 0.000 claims 10
- 108020005497 Nuclear hormone receptor Proteins 0.000 claims 10
- 229910052799 carbon Inorganic materials 0.000 claims 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- 206010060862 Prostate cancer Diseases 0.000 claims 6
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 5
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 3
- 239000003098 androgen Substances 0.000 claims 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 claims 2
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- HGINADPHJQTSKN-UHFFFAOYSA-M 3-ethoxy-3-oxopropanoate Chemical compound CCOC(=O)CC([O-])=O HGINADPHJQTSKN-UHFFFAOYSA-M 0.000 claims 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 206010020112 Hirsutism Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 206010064930 age-related macular degeneration Diseases 0.000 claims 1
- 150000001718 carbodiimides Chemical class 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000012320 chlorinating reagent Substances 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- VRHAQNTWKSVEEC-UHFFFAOYSA-N ethyl 1,3-dioxoisoindole-2-carboxylate Chemical compound C1=CC=C2C(=O)N(C(=O)OCC)C(=O)C2=C1 VRHAQNTWKSVEEC-UHFFFAOYSA-N 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims 1
- 210000004897 n-terminal region Anatomy 0.000 claims 1
- 208000025661 ovarian cyst Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 208000006155 precocious puberty Diseases 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13627708P | 2008-08-22 | 2008-08-22 | |
| US61/136,277 | 2008-08-22 | ||
| PCT/CA2009/001173 WO2010020055A1 (en) | 2008-08-22 | 2009-08-24 | Small molecule inhibitors of n-terminus activation of the androgen receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012500778A JP2012500778A (ja) | 2012-01-12 |
| JP2012500778A5 true JP2012500778A5 (enExample) | 2012-10-11 |
Family
ID=41706796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523280A Abandoned JP2012500778A (ja) | 2008-08-22 | 2009-08-24 | アンドロゲン受容体のｎ末端の活性化の小分子阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9487479B2 (enExample) |
| EP (1) | EP2331501B1 (enExample) |
| JP (1) | JP2012500778A (enExample) |
| CN (1) | CN102131775B (enExample) |
| AU (1) | AU2009284668B2 (enExample) |
| BR (1) | BRPI0917818A2 (enExample) |
| CA (1) | CA2728103C (enExample) |
| CL (1) | CL2011000341A1 (enExample) |
| CO (1) | CO6351779A2 (enExample) |
| ES (1) | ES2593859T3 (enExample) |
| MX (1) | MX339300B (enExample) |
| RU (1) | RU2519948C2 (enExample) |
| WO (1) | WO2010020055A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0917818A2 (pt) | 2008-08-22 | 2017-02-21 | British Columbia Cancer Agency Branch | composto, método para modular a atividade de ar, uso de composto, composição farmacêutica, e, para preparar um composto |
| AU2015266654A1 (en) * | 2014-05-30 | 2016-12-01 | British Columbia Cancer Agency Branch | Androgen receptor modulators and methods for their use |
| TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
| US10799416B2 (en) * | 2017-01-11 | 2020-10-13 | Jonathan Taves | Self-treating upper neck system for therapeutic mobilization |
| CN107468690B (zh) * | 2017-08-11 | 2020-01-31 | 北京卓凯生物技术有限公司 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法与应用 |
| CN107353239B (zh) | 2017-08-11 | 2019-06-18 | 北京卓凯生物技术有限公司 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法 |
| RU2700573C2 (ru) * | 2017-10-16 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Способ лечения кастрационно-устойчивого рака простаты |
| RU2694259C2 (ru) * | 2017-10-16 | 2019-07-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Способ лечения кастрационно-устойчивого рака простаты |
| RU2694373C2 (ru) * | 2017-10-16 | 2019-07-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Способ лечения кастрационно-устойчивого рака простаты |
| RU2696287C2 (ru) * | 2017-10-16 | 2019-08-01 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Способ лечения кастрационно-устойчивого рака простаты |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0317057A (ja) * | 1989-06-15 | 1991-01-25 | Fujisawa Pharmaceut Co Ltd | 新規５員環複素環化合物 |
| WO2000001813A2 (en) | 1998-06-30 | 2000-01-13 | The University Of British Columbia | Peptide inhibitors of androgen-independent activation of androgen receptor |
| WO2001095858A2 (en) * | 2000-05-09 | 2001-12-20 | Adpharma, Inc. | Piperazinedione compounds |
| GB0130677D0 (en) * | 2001-12-21 | 2002-02-06 | Glaxo Group Ltd | Medicaments and novel compounds |
| US7772433B2 (en) | 2002-02-28 | 2010-08-10 | University Of Tennessee Research Foundation | SARMS and method of use thereof |
| BRPI0917818A2 (pt) | 2008-08-22 | 2017-02-21 | British Columbia Cancer Agency Branch | composto, método para modular a atividade de ar, uso de composto, composição farmacêutica, e, para preparar um composto |
| AU2015266654A1 (en) | 2014-05-30 | 2016-12-01 | British Columbia Cancer Agency Branch | Androgen receptor modulators and methods for their use |
-
2009
- 2009-08-24 BR BRPI0917818A patent/BRPI0917818A2/pt not_active IP Right Cessation
- 2009-08-24 ES ES09807798.5T patent/ES2593859T3/es active Active
- 2009-08-24 AU AU2009284668A patent/AU2009284668B2/en active Active
- 2009-08-24 MX MX2011001890A patent/MX339300B/es active IP Right Grant
- 2009-08-24 WO PCT/CA2009/001173 patent/WO2010020055A1/en not_active Ceased
- 2009-08-24 US US12/999,035 patent/US9487479B2/en active Active
- 2009-08-24 JP JP2011523280A patent/JP2012500778A/ja not_active Abandoned
- 2009-08-24 CA CA2728103A patent/CA2728103C/en active Active
- 2009-08-24 CN CN200980132751.6A patent/CN102131775B/zh active Active
- 2009-08-24 EP EP09807798.5A patent/EP2331501B1/en active Active
- 2009-08-24 RU RU2011110743/04A patent/RU2519948C2/ru active
-
2011
- 2011-02-17 CL CL2011000341A patent/CL2011000341A1/es unknown
- 2011-03-22 CO CO11034471A patent/CO6351779A2/es not_active Application Discontinuation
-
2016
- 2016-09-27 US US15/277,733 patent/US20170239216A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012500778A5 (enExample) | ||
| JP7536721B2 (ja) | キナーゼを修飾する１ｈ－ピロロ［２，３－ｂ］ピリジン誘導体の合成 | |
| RU2011110743A (ru) | Низкомолекулярные ингибиторы n-концевой активации рецептора андрогенов | |
| TWI312347B (en) | Bicyclic nitrogen-containing condensed ring compounds | |
| CA2866080C (en) | Ros-activated compounds as selective anti-cancer therapeutics | |
| MX2010008101A (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica. | |
| JP2012520861A5 (enExample) | ||
| JP2014510774A5 (enExample) | ||
| WO2009112678A3 (fr) | Derives de carboxam i d es azabicycliques, leur preparation et leur application en therapeutique. | |
| JP2018532759A (ja) | ピリミジン誘導体及びその使用 | |
| KR20140035493A (ko) | 중수소 농축된 4-하이드록시-5-메톡시-ｎ,1-다이메틸-2-옥소-ｎ-[(4-트리플루오로-메틸)페닐]-1,2-다이하이드로퀴놀린-3-카르복사미드 | |
| TNSN07469A1 (en) | N-(heteroaryl) -1- heteroarylalkyl -1h-indole-2- carboxamide derivatives, preparation and use thereof | |
| TW201825510A (zh) | 細胞穿透肽序列 | |
| WO2018136935A1 (en) | 2-arylsulfonamido-n-arylacetamide derivatized stat3 inhibitors | |
| ES2375640T3 (es) | Amidinas de piperizina como agentes antivirales. | |
| ES2911183T3 (es) | Compuesto para inhibir selectivamente quinasas y uso del mismo | |
| AU2019326768B2 (en) | 2,6-bis(((1H-benzo[d]imidazol-2-yl)thio)methyl)pyridine and N2,N6-dibenzylpyridine-2,6-dicarboxamide derivatives and related compounds as phosphoinositide 3-kinase (PI3K) inhibitors for treating cancer | |
| WO2023143147A1 (zh) | 一种哒嗪并吡啶酮类化合物、其药物组合物及应用 | |
| CN111491937A (zh) | 作为精氨酸酶抑制剂的杂环化合物 | |
| TWI262190B (en) | IP3 receptor ligand | |
| CN105732643A (zh) | 一种偶联物、其制备方法及在制备ido酶抑制剂和非甾体抗炎药物中的应用 | |
| TW200808728A (en) | Method of preparing 4-halogenated quinoline intermediates | |
| EA016323B1 (ru) | Производные сулиндака, их применение и получение | |
| WO2021062168A1 (en) | Synthetic sphingolipid inspired molecules with heteroaromatic appendages, methods of their synthesis and methods of treatment | |
| JP2008544975A5 (enExample) |